Cite
HARVARD Citation
Roussel, R. et al. (2021). Use of dipeptidyl peptidase‐4 inhibitors and prognosis of COVID‐19 in hospitalized patients with type 2 diabetes: A propensity score analysis from the CORONADO study. Diabetes, obesity & metabolism. 23 (5), pp. 1162-1172. [Online].